ICONIC: Phase 1/2 trial of ICOS agonist JTX-2011 alone and in combination with nivolumab (nivo)

Category Primary study
JournalCANCER RESEARCH
Year 2017
This article has no abstract
Epistemonikos ID: 02b8be862303015b8e04615a6279a862c548a86b
First added on: Feb 08, 2025